Online inquiry

IVTScrip™ mRNA-Human ANKRD13A, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17900MR)

This product GTTS-WK17900MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD13A protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_033121.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 88455
UniProt ID Q8IZ07
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD13A, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17900MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK23969MR IVTScrip™ mRNA-Human ATN1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ATN1
GTTS-WK27765MR IVTScrip™ mRNA-Human ARPC1A, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARPC1A
GTTS-WK28000MR IVTScrip™ mRNA-Human ARHGAP45, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGAP45
GTTS-WK8088MR IVTScrip™ mRNA-Human AGAP2, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AGAP2
GTTS-WK20543MR IVTScrip™ mRNA-Human ALS2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ALS2
GTTS-WK21686MR IVTScrip™ mRNA-Human ARHGAP20, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP20
GTTS-WK26491MR IVTScrip™ mRNA-Human ARHGAP26, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARHGAP26
GTTS-WK17923MR IVTScrip™ mRNA-Human ANKRD37, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD37
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →